U.S. Other Utilities Stock News

NasdaqGS:PEGA
NasdaqGS:PEGASoftware

What Pegasystems (PEGA)'s Weaker Q1, Legal Settlement, and AI Blueprint Momentum Means For Shareholders

Pegasystems Inc. earlier reported first-quarter 2026 results showing revenue of US$429.97 million and net income of US$32.76 million, both lower than a year earlier, while separately moving to settle derivative actions with a US$7 million special cash dividend and governance reforms. Alongside these financial and legal developments, Pegasystems highlighted growing traction for its AI-native Blueprint architecture, which is helping shorten sales cycles and expand its new-customer...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

A Look At BBB Foods (TBBB) Valuation After Recent Share Price Softness

What BBB Foods’ Recent Returns Signal for Investors BBB Foods (TBBB) has drawn attention after a 1-day return of around -1.3%, adding to a past 3 months return near -4.4%, even as its 1-year total return is about 16.9%. See our latest analysis for BBB Foods. This recent 1-day share price return of around 1.3% decline sits within a softer 3 month share price return near 4.5% decline, while the 1 year total shareholder return of about 16.9% still reflects a stronger longer term outcome. If you...
NYSE:ODC
NYSE:ODCHousehold Products

A Look At Oil-Dri (ODC) Valuation After Recent Share Price Pullback And Strong Multi Period Returns

Stock performance snapshot and recent returns Oil-Dri Corporation of America (ODC) has drawn investor attention after recent share price moves, with the stock showing a 1.7% decline over the past day and a 2.3% decline over the past week. Even with those shorter term pullbacks, the stock reflects a 6.6% gain over the past month and a 16.4% gain over the past 3 months, alongside a year-to-date return of 48.7% and a 1 year total return of 66.6%. See our latest analysis for Oil-Dri Corporation...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

A Look At Mirum Pharmaceuticals (MIRM) Valuation After Positive VISTAS Phase 2b Volixibat Results

Mirum Pharmaceuticals (MIRM) is back in focus after reporting that its VISTAS Phase 2b trial of volixibat in primary sclerosing cholangitis met the primary endpoint of reducing cholestatic pruritus with favorable safety. See our latest analysis for Mirum Pharmaceuticals. Investors appear to be responding to Mirum's recent clinical updates, with the 1-day share price return of 9.59% and 7-day share price return of 14.39% contributing to a 35.51% year to date share price return, alongside a...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

A Look At Interactive Brokers Group (IBKR) Valuation After Strong Recent Share Price Momentum

Recent share performance and business scale Interactive Brokers Group (IBKR) has drawn fresh attention after a strong run in its share price, with the stock showing positive returns over the past week, month and past 3 months. At a last close of US$81.72, the company carries a market value of about US$136.5b. Over the past year, total return is reported at 83%, with 3 year and 5 year total returns also very large. See our latest analysis for Interactive Brokers Group. The recent 1 month share...
NYSE:BEN
NYSE:BENCapital Markets

Why Franklin Resources (BEN) Is Up 7.7% After Strong Q2 2026 Earnings Beat And Guidance Lift

In the past quarter, Franklin Resources, Inc. reported second-quarter 2026 results showing year-over-year growth in sales to US$396.6 million, revenue to US$2.29 billion, and net income to US$268.2 million, with basic and diluted earnings per share from continuing operations rising to US$0.49. These stronger earnings, combined with higher preliminary assets under management of about US$1.74 billion and long-term net inflows, have reinforced the view that Franklin Resources’ business...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

How Margin Pressures and Softer Q2 Outlook Will Impact Acadia Healthcare Company (ACHC) Investors

In April 2026, Acadia Healthcare Company, Inc. reported first-quarter 2026 results showing revenue of US$828.8 million but lower net income of US$4.11 million and earnings per share of US$0.05 from continuing operations compared with the prior year, while also issuing second-quarter revenue guidance of US$835 million to US$850 million and reaffirming its full-year 2026 revenue outlook. At the same time, the company flagged margin pressure from startup losses, higher bad debts, legal...
NYSE:EAT
NYSE:EATHospitality

Did Brinker’s Upgraded 2026 Guidance and Chili’s Sales Streak Just Shift Brinker International's (EAT) Investment Narrative?

Brinker International recently reported its third-quarter 2026 results, with revenue rising to US$1,470.2 million and net income at US$127.9 million, and modestly raised full-year 2026 revenue and non-GAAP EPS guidance to ranges of US$5.78–5.82 billion and US$10.60–10.85 per diluted share, respectively. The guidance lift came alongside Chili’s achieving its 20th consecutive quarter of same-store sales growth and early success from a new chicken sandwich platform, highlighting how focused...
NasdaqGS:UVSP
NasdaqGS:UVSPBanks

Univest Financial (UVSP) Valuation Check After Strong Q1 Results And Shareholder Return Updates

Univest Financial (UVSP) has been in focus after first quarter 2026 results showed higher net interest income and earnings, alongside a quarterly dividend increase and continued progress under its long running share repurchase program. See our latest analysis for Univest Financial. At a share price of $38.16, Univest Financial has posted an 18.22% year-to-date share price return, while its 1-year total shareholder return of 28.57% and very large 3-year total shareholder return suggest...
NYSE:ESS
NYSE:ESSResidential REITs

Should Essex’s Higher 2026 Guidance and Buybacks Require Action From Essex Property Trust (ESS) Investors?

Essex Property Trust recently reported first-quarter 2026 results showing higher revenue of US$484.76 million but lower net income of US$106.19 million, while also completing US$259.24 million of share repurchases under its October 2022 buyback program. Alongside this, the company raised its full-year 2026 net income guidance per diluted share and highlighted a core FFO beat supported by resilient rent and occupancy trends across its West Coast portfolio. We will now examine how Essex’s...
NYSE:TE
NYSE:TESemiconductor

A Look At T1 Energy’s Valuation After New AI Server Farm Contracts In The US And Europe

T1 Energy (TE) is back in focus after securing new contracts in the United States and Europe to support AI server farms, highlighting its role in resilient, autonomous energy systems and long-duration revenue visibility. See our latest analysis for T1 Energy. The stock has been volatile, with a 21.72% 1 month share price return but a 43.89% 3 month share price decline and a year to date share price return of 34.95% in negative territory. The 1 year total shareholder return is very large,...
NasdaqGM:APGE
NasdaqGM:APGEBiotechs

Should Zumilokibart’s Phase 2 Data and Insider Sales Activity Require Action From Apogee Therapeutics (APGE) Investors?

Apogee Therapeutics recently reported promising Phase 2 trial results for its lead drug candidate zumilokibart in atopic dermatitis, alongside new bullish analyst coverage that highlighted the therapy’s potential for very infrequent dosing. Insider Jane Henderson also disclosed multiple pre-planned sales of restricted stock earlier this year, underscoring how management is gradually monetizing prior equity awards while clinical data raise the company’s profile. We’ll now examine how the...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Is It Time To Reconsider Super Micro Computer (SMCI) After Recent Price Swings And DCF Results

If you are wondering whether Super Micro Computer stock is priced fairly or if the recent moves have left value on the table, this article breaks down what the current valuation signals might be telling you. Over the past month the stock price has changed by 20.2%, while the 1-year return shows a 13.2% decline and the 3-year return stands at 104.3%. Together, these figures present a mixed picture of how the market has treated the stock over different timeframes. Recent coverage has focused...
NYSE:A
NYSE:ALife Sciences

Does Agilent’s New Chief Legal Officer Shift the Risk‑Reward Balance in Its Strategy (A)?

Agilent Technologies has recently completed a leadership transition, appointing Michael Buckner as Chief Legal Officer after Bret DiMarco resigned and moved into a Special Advisor role to support the handover. This change puts an experienced legal executive at the center of Agilent’s regulatory, M&A, and governance agenda, with potential implications for risk management and corporate decision‑making. Next, we’ll explore how Buckner’s appointment as Chief Legal Officer could influence...
NYSE:AMRC
NYSE:AMRCConstruction

Ameresco (AMRC) Valuation Check After Stronger Sales And Wider Loss In Latest Quarterly Results

Ameresco (AMRC) is back in focus after first quarter 2026 results showed sales of US$401.46 million compared with US$352.83 million a year earlier, alongside a wider net loss of US$18.28 million. See our latest analysis for Ameresco. The latest results and recent appearance at a major data center trade show have kept Ameresco in the spotlight. The stock has responded with a 12.79% 7 day and 28.02% 30 day share price return, while the 1 year total shareholder return of 170.68% contrasts with...
NYSE:CRGY
NYSE:CRGYOil and Gas

Why Crescent Energy (CRGY) Is Up 7.3% After Q1 Revenue Jump But Wider GAAP Loss And What's Next

Crescent Energy reported first-quarter 2026 results with revenue rising to US$1,182.83 million from US$950.17 million a year earlier, while net loss widened to US$419.85 million and GAAP loss per share increased to US$1.28. Behind the headline loss, Crescent Energy delivered strong operational momentum, including robust year-on-year oil production growth and non-GAAP earnings per share that exceeded analyst expectations. We’ll now examine how Crescent’s strong revenue growth but much larger...
NYSE:ZGN
NYSE:ZGNLuxury

How Investors Are Reacting To Ermenegildo Zegna (ZGN) Q1 Revenue Uptick And Confirmed Cash Dividend

Ermenegildo Zegna N.V. has already reported unaudited first-quarter 2026 revenues of €470,175,000, up from €458,821,000 a year earlier, and confirmed an annual dividend of US$0.1200 per share payable on July 29, 2026, subject to prior ex-dividend and record dates on July 6, 2026. The results highlight how Zegna’s push toward direct-to-consumer sales and brand elevation is reshaping its revenue mix and reinforcing its business model. We’ll now examine how this stronger direct-to-consumer...
NasdaqGS:SRCE
NasdaqGS:SRCEBanks

A Look At 1st Source (SRCE) Valuation After Q1 Results And Dividend Increase

1st Source (SRCE) is back in focus after first quarter 2026 results paired higher net interest income and net income with a sharp rise in net charge offs and a larger quarterly dividend. See our latest analysis for 1st Source. The stock has had a softer 1 day share price return of 1.08% and a 7 day share price return of 1.00%. However, a 16.97% year to date share price return and 22.88% 1 year total shareholder return point to momentum that has built over time. Recent buybacks, higher net...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Strong Q1 Results And Raised Revenue Guidance

Kiniksa Pharmaceuticals International (KNSA) recently reported first quarter 2026 results, with revenue of US$214.27 million and net income of US$22.59 million, and raised its full year net product revenue guidance. See our latest analysis for Kiniksa Pharmaceuticals International. The share price has responded strongly to the Q1 2026 results and higher net product revenue guidance, with a 7 day share price return of 32.13% adding to a 37.17% year to date share price return and a 1 year total...
NYSE:CWT
NYSE:CWTWater Utilities

A Look At California Water Service Group (CWT) Valuation After Mixed First Quarter 2026 Earnings

California Water Service Group (CWT) drew investor focus after first quarter 2026 results showed sales of US$214.57 million versus US$203.97 million a year earlier, while net income and earnings per share were lower. See our latest analysis for California Water Service Group. The stock has been relatively flat year to date with a 0.23% share price return. A 1 day gain of 1.63% contrasts with weaker 7 day and 30 day share price returns and a 1 year total shareholder return decline of 9.75%,...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

Did Fast Track Rezpegaldesleukin Data and New Hires Just Shift Nektar Therapeutics' (NKTR) Investment Narrative?

Nektar Therapeutics recently reported new 52-week maintenance data for its immune-modulating drug rezpegaldesleukin in atopic dermatitis and shared additional Phase 2b results in alopecia areata, both supported by FDA Fast Track designations. The company also granted stock options and restricted stock units to six newly hired employees under its 2025 Inducement Plan, underscoring its efforts to attract talent as it advances late-stage clinical programs. Next, we’ll examine how the latest...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL) Valuation Check After Strong Q1 2026 Results And Higher Earnings Guidance

Quarterly results and new guidance draw fresh attention to Globe Life stock Globe Life (GL) is back on investor radars after first quarter 2026 results showed higher revenue and net income than a year earlier, along with raised full year earnings guidance and an updated capital return picture. See our latest analysis for Globe Life. Globe Life’s share price has climbed 10.28% year to date and 7.05% over the last month, while its 1 year total shareholder return of 26.72% and 5 year total...
NYSE:WT
NYSE:WTCapital Markets

Tokenized Money Markets, Record AUM, Atlantic House Deal Might Change The Case For Investing In WisdomTree (WT)

In the first quarter of 2026, WisdomTree, Inc. reported revenue of US$159.47 million versus US$108.08 million a year earlier, moved from net income of US$24.63 million to a net loss of US$23.13 million, affirmed a quarterly dividend of US$0.03 per share, and expanded its digital footprint through a new tokenized money market access partnership with Stable Sea. Alongside record assets under management of about US$152.60 billion and the completed acquisition of Atlantic House, WisdomTree is...
NYSE:CCS
NYSE:CCSConsumer Durables

A Look At Century Communities (CCS) Valuation After Weaker Q1 Results And Lower Full Year Guidance

Century Communities (CCS) stock has been reacting to fresh first quarter earnings, with the homebuilder reporting lower revenue and net income and trimming its full year home delivery and sales outlook. See our latest analysis for Century Communities. The earnings miss and reduced full year guidance have weighed on sentiment, with a 1 day share price return of 7%, extending to a 21.3% 3 month share price decline and a 28.9% 5 year total shareholder return decline that points to fading...